Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shijiazhuang Yiling Pharmaceutical Co., Ltd.
  6. Summary
    002603   CNE1000015S0

SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.

(002603)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-12-08
50.88 CNY   -1.70%
05:23aInvestors bet on greed and fear as China loosens COVID grip
RE
12/08Yiling to Boost Production of Traditional Herbal Medicine for Flu; Shares Rally 7%
MT
11/16China, HK stocks drop on COVID outbreaks, geopolitical risks
RE
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
12/05/2022 12/06/2022 12/07/2022 12/08/2022 12/09/2022 Date
45.6 44.65 49.12 51.76 50.88 Last
188964400 217039300 228743000 260003800 207316000 Volume
+8.29% -2.08% +10.01% +5.37% -1.70% Change
Estimated financial data (e)
Sales 2022 11 204 M 1 611 M 1 611 M
Net income 2022 1 646 M 237 M 237 M
Net cash position 2022 9,50 M 1,37 M 1,37 M
P/E ratio 2022 51,7x
Yield 2022 0,74%
Sales 2023 13 121 M 1 886 M 1 886 M
Net income 2023 1 979 M 284 M 284 M
Net cash position 2023 841 M 121 M 121 M
P/E ratio 2023 43,0x
Yield 2023 0,74%
Capitalization 85 005 M 12 220 M 12 220 M
EV / Sales 2022 7,59x
EV / Sales 2023 6,41x
Nbr of Employees 15 155
Free-Float 41,0%
More Financials
Company
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company mainly provides cardiovascular and cerebrovascular drugs and anti-cold drugs. The Company also provides food and beverage products. The Company distributes its products within domestic market and to overseas markets. 
Sector
Pharmaceuticals
Calendar
04/27Earnings Release
More about the company
Ratings of Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
05:23aInvestors bet on greed and fear as China loosens COVID grip
RE
12/08Yiling to Boost Production of Traditional Herbal Medicine for Flu; Shares Rally 7%
MT
11/16China, HK stocks drop on COVID outbreaks, geopolitical risks
RE
11/15China, HK stocks drop on COVID outbreaks, geopolitical risks
RE
11/15Yiling Pharma Seeks Clinical Trial of Chinese Medicine Against Colds; Shares Rally 5%
MT
10/27Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Mont..
CI
08/25Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year..
CI
07/12Shijiazhuang Yiling Pharmaceutical Co., Ltd. Announces Final Dividend on Share A for 20..
CI
05/27Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021
CI
05/02Yiling Pharmaceutical's Q1 Profit Tumbles 28% as Sales Plummet
MT
04/29Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year ..
CI
04/28Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Qua..
CI
04/18Yiling Pharma's Shares Sink on Doubts Over COVID-19 Drug Efficacy
MT
2021Shunten International Limited Enters into Cooperation Framework Agreement with Shijiazh..
CI
2021Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced a financing transaction
CI
More news
News in other languages on SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
05:23aLes investisseurs misent sur la cupidité et la peur alors que la Chine desserre l'étau ..
12/08Yiling va augmenter sa production de médicaments traditionnels à base de plantes contre..
12/07LATE BRIEFING - Unternehmen und Märkte
12/07MIDDAY BRIEFING - Unternehmen und Märkte
12/07MÄRKTE ASIEN/Zins- und Rezessionssorgen bremsen - Achterbahnfahrt in China
More news
ETFs positioned on SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
VanEck New China ESG - USD0.96%3.02%-NC
KraneShares Emerging Market Healthcare Inde...0.72%0.51%NC
KraneShares MSCI All China Health Care Inde...0.71%3.30%China
Global X MSCI China Health Care ETF - USD0.38%2.23%China
Xtrackers Harvest CSI 500 China-A Shares Sm...0.29%1.49%China
More ETFs positioned on SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
Chart SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
Duration : Period :
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 50,88 CNY
Average target price 33,05 CNY
Spread / Average Target -35,0%
EPS Revisions
Managers and Directors
Xiang Jun Wu Director & General Manager-Marketing Center
Chen Guang Li Chief Financial Officer & Director
Yi Ling Wu Chairman
Xue Dong Gao Chairman-Supervisory Board
Zhen Wang Independent Director